Could we finally have a faster, more objective analytical tool to rapidly measure viral infectivity for vaccine development and production? Scientists and bioengineers at Thermo Fisher Scientific and LumaCyte believe we do. This peer reviewed work will be published on September 12th in the prestigious journal, Vaccine, by Elsevier, detailing how LumaCyte’s RadianceTM instrument, based on…